ANI Pharmaceuticals (ANIP) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 21, 2026, to be held virtually for shareholder participation.

• Shareholders are encouraged to review proxy materials and vote online or during the meeting.

Voting matters and shareholder proposals

• Election of seven directors is up for shareholder vote, with all nominees recommended by the board.

• Ratification of Ernst & Young LLP as independent auditor for the fiscal year ending December 31, 2026.

• Advisory vote on executive compensation (say-on-pay) and on the frequency of future say-on-pay votes, with the board recommending annual votes.

• Approval of the Amended and Restated 2022 Stock Incentive Plan is proposed.

• Provision to transact other business as may properly come before the meeting, including adjournments or postponements.

Board of directors and corporate governance

• Seven director nominees are presented for election, including individuals with pharmaceutical and executive experience.